SLC6A3 and Parkinson disease: Moreover, the PD‐DH subtype also showed higher scores and faster progressions in motor symptom measurements, including the MDS‐UPDRS Part II and Part III scores, and was found to experience a more rapid decline in caudate DAT uptake and CSF α‐syn levels during follow‐up.